
NOVADIP
Developer of cell-based regeneration therapies designed to develop a new class of regenerative tissue products to accelerate the healing of large bone defects, bone non-union, and spine fusion in a si...
Valuation
$0
Share Price
N/A
Total Raised
$107.8M
Last Round
N/A